Cardiovascular device firms of every shape and size - small caps, medium caps, big caps, early stage, development-stage and commercialization stage - took part in the 24th annual JPMorgan Healthcare Conference at the packed-as-usual Westin St. Francis Hotel early last month. The fact that nearly all of them drew standing-room-only audiences to their respective presentation venues shows the continuing interest the sector holds for the investment community.